Giant Biogene Holding Co (HKSE:02367) Ending Cash Position : HK$2,739 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co Ending Cash Position?

Giant Biogene Holding Co's Ending Cash Position for the quarter that ended in Dec. 2023 was HK$2,739 Mil.

Giant Biogene Holding Co's quarterly Ending Cash Position increased from Dec. 2022 (HK$1,486 Mil) to Jun. 2023 (HK$1,704 Mil) and increased from Jun. 2023 (HK$1,704 Mil) to Dec. 2023 (HK$2,739 Mil).

Giant Biogene Holding Co's annual Ending Cash Position declined from Dec. 2021 (HK$8,697 Mil) to Dec. 2022 (HK$1,486 Mil) but then increased from Dec. 2022 (HK$1,486 Mil) to Dec. 2023 (HK$2,739 Mil).

Giant Biogene Holding Co Ending Cash Position Historical Data

The historical data trend for Giant Biogene Holding Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co Ending Cash Position Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

80.48

436.01

8,697.39

1,486.29

2,738.82

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial			-	978.42	1,486.29	1,703.57	2,738.82

Giant Biogene Holding Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Giant Biogene Holding Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1455.767	+	1283.054
	=	2,739

Giant Biogene Holding Co's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1703.57	+	1035.251
	=	2,739

Giant Biogene Holding Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Executives

Refulgence Holding Limited	2201 Interest of corporation controlled by you
Juzi Holding Co., Ltd	2101 Beneficial owner
Fan Daidi	2201 Interest of corporation controlled by you
Yan Jianya	2202 Interest of your spouse
Yi Fang Da Ji Jin Guan Li You Xian Gong Si	2102 Investment manager
Yan Jianya	2101 Beneficial owner
Fan Daidi
Trident Trust Company (b.v.i.) Limited	2301 Trustee

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines